Kaposi's sarcoma (KS) developed in a patient with human T-cell leukemia virus type I (HTLV-1)-associated adult T-cell
Infection with HTLV-I was affirmed by the presence of circulating antibodies specific for HTLV-I antigens by an enzyme-linked immunosorbent assay (ELISA) and by demonstration of HTLV-I proviral DNA clonally integrated in host genome on Southern hybridization (Fig 1) .
The patient was seronegative for antibodies to HIV by ELISA on three separate occasions. Further exclusion of a concurrent HIV infection was aggressively pursued. Genomic DNA isolated from the patient's peripheral mononuclear cells was subjected to specific gene individual should alert investigators to the occurrence of KS in retroviral-associated diseases other than acquired immunodeficiency disease syndrome. Recognition of the similarities and differences between HTLV-I and HIV infections may provide insights concerning the angiopathogenesis of KS. 0 1990 by The American Society of Hematology.
sequence amplification by the polymerase chain reaction.'" By this technique, genotyping for pol and gag regions of the HIV provirus was negative and effectively ruled out HIV infection*' (Fig 1) . However, the patient was positive for cytomegalovirus infection (high serum antibody titers and virus isolated from urine) and acute hepatitis B viral infection (serum hepatitis B surface antigen positive). In addition, Isospora belli oocysts were recovered from stool, reflecting an ongoing opportunistic gastroenteritis.
The patient was anergic on skin testing against Tetanus and Diphtheria toxoids and Streptococcus group C, tuberculin, Candida, Trichophyton, and Proteus antigens. Thirty-four percent of the peripheral blood lymphocyte population were CD4' and 4% were CD8 +. Serum and cerebrospinal fluid protein electrophoresis, immunoglobulin levels, and complement (CH50) were normal.
Immunotherapy consisted of 11 courses over a 7-week period of intravenously administered anti-Tar, an MoAb directed against the 55-Kd peptide a chain of the IL-2R.22 A partial remission ensued and the total white blood cell count decreased from 26,200 to 3,000 to 4,000/mm3 with a parallel decline from over 70% to 1% to 2% circulating abnormal lymphocytes. The number of Tac-positive cells declined from 23,000 to 340/mm' (normal up to SOO/mm3), and the serum level of soluble IL-2Ra decreased from 35,000 to 2,000 U/mL. One month after immunotherapy, delayed-type hypersensitivity developed to six recall skin test antigens to which the patient was previously anergic. I belli gastroenteritis responded well to oral sulfamethoxazole/ trimethoprim. '" At a 4-month follow-up the patient appeared in general good health, but was concerned about the interim development of multiple hyperpigmented, firm, nonblanching papules distributed over the chest and extremities. The borders were distinct and some of the lesions had a linear configuration ranging up to 15 mm in the long axis. The lesions were nonpruritic, painless, and did not involve the mucous membranes (Fig 2) . Biopsies of right medial thigh and left deltoid lesions showed findings diagnostic of KS (Fig 3) . patients, are anergic when skin-tested with standard recall antigens. In this regard the in vivo cellular immunity of our patient was distinctive. Our ATL patient was anergic during an active phase of his leukemia before anti-Tac therapy and before the appearance of KS lesions. He subsequently developed delayed-type hypersensitivity responses during the presentation of KS and while in an anti-Tac induced state of partial leukemic remission, but became anergic once again during the terminal malignant course. Coincidentally, with the recurrence of the ATL the KS greatly resolved and many of the lesions were subsequently infiltrated with leukemic cells. This variable presentation of KS in relation to the clinical course of ATL is suggestive of a secondarily induced, multicentric proliferative response of endothelial and spindle cell elements.
The contribution of monoclonal immunotherapy to the development of KS is uncertain, although it is unlikely that the KS arose secondary to a state of induced immunosuppression. Indeed, cellular immunity, reflected by delayed-type hypersensitivity skin testing, normalized after treatment with anti-Tac, and subsequent treatment with anti-Tac at a time when KS lesions were resolving was not followed by an exacerbation of KS. In contradistinction to the receptor blocking effects of anti-Tac, the simulatanwus administration of IL-2 and &interferon has been associated with It has been postulated that the aberrant viral transactivation of host genes may lead to specific pathophysiologic states associated with retroviral infection.)' In this regard, KS-like lesions develop in mice transgenic for the HIV LTR-tat construct:' growth of AIDS-KS-derived cells are supported by factors released from HTLV and HIV-infected T-cell and cultured AIDS-KS cells produce autocrine and paracrine growth factors34 with angiogenic activity.)' Alternatively, the elaboration of potent KS-associated growth factors may result from activation of an as yet uncharacterized KS Finally, it is possible that the mesenchymal cell elements were directly stimulated by factors released from the killing of leukemic cells after therapy, although we have no evidence for this particular process.
Collectively, these findings suggest that retroviral-associated KS is not a malignancy of clonal origin, but rather a secondary hyperproliferation of vascular and lymphatic elements in response to cellular-derived paracrine or autocrine growth factor^.'^ There was an admixture of CD4 cells (ratio approximately 3:l). The cutaneoua lymphoid infiltrate waa not positive with anti-Tac, but occasional poaitiva cells were aoen with 7G7/88. an MoAb that alao detects the IL-2Rn." Section. atained only with goet anti-mouae immunoglobulin were negative, failing to ahow reaidually bound anti-Tsc that had h e n administered tharapeuthlly. The lymph node biopsy obtained 1 6 months a f t r preaentetion ahowed diffuae replacement by mlignent lymphoma composed of pleomorphic lymphoid cells consistent with ATL" " (not ahown here). Immunohiatochemical analysis on frozen aectiona of the lymph node damonatrated T-cell markra characteristic of ATL: CD3 ' . CD2 . CD5 , CD7 ." The cella were weakly and focally poaitive for C M but totslly negative for 0 8 . The cella were atrongly poaitive with both snti-Tac and 7 G 7 / 8 6 . No staining waa obaerved for E-cell-assochted antigena CD20. CD19. and CD22. and aurface immunoglobulin heavy and light chain..
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The inverse relationship between ATL and KS disease activity in the present case, although not defined, may provide a clue to the pathogenic mechanism underlying HTLV-I infection. During active ATL, suppression of certain T-cell parallels the absence of expression among clonal circulating ATL cells of the messenger R N A for the transactivating element, whereas the pX transcriptional element is expressed in the polyclonal cells of non-ATL individuals infected with HTLV-I.39 Thus, development of KS during ATL remission may reflect up-regulation of the retroviral transactivator element and consequent Tuxinduced cytokine expression. Remission of KS at the time of ATL recurrence may reflect eclipse of Tux expression with consequent down-regulation of T-cell-derived products that may act as paracrine factors stimulating Kaposi cell proliferation.
Recent advances have suggested that AIDS-related KS represents a secondary proliferative response of spindle cell elements to paracrine growth factors. This process may not be unique to retroviral infection with HIV. The documentation of HTLV-I-associated ATL-related KS may suggest that a similar mechanism of retroviral induction of cellular growth factors by HTLV-I is possible.
